NasdaqGS:IRTCMedical Equipment
iRhythm Technologies (IRTC): Valuation in Focus After DOJ Probe and FDA Safety Concerns Shake Confidence
If you’ve been following iRhythm Technologies (IRTC) lately, the latest headlines may have you pausing to reconsider your next move. Spruce Point Capital Management has issued new reports raising major red flags about the safety of iRhythm’s core Zio cardiac monitoring device, citing FDA-identified deficiencies and linking the company to potential patient harm. Just as those concerns reached the news cycle, word broke that the Department of Justice is investigating whether company executives...